Institutional investors purchased a net $24.3 million shares of GILD during the quarter ended June 2016 and now own 81.64% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CAPITAL RESEARCH & MANAGEMENT CO... Bought 3.4 Million shares of Gilead Sciences
PARNASSUS INVESTMENTS Bought 2.6 Million shares of Gilead Sciences
GOLDMAN SACHS & CO. (PRIVATE BAN... Bought 2.1 Million shares of Gilead Sciences